GoKawiil
Still conscious? Brain marker signals when anaesthesia takes hold
(feeds.nature.com)
91.
92.
Treatments for idiopathic pulmonary fibrosis are on the horizon
(feeds.nature.com)
93.
Caribbean cannabis growers eye budding domestic sales and exports
(feeds.bbci.co.uk)
95.
96.
ADHD treatments move beyond stimulants
(feeds.nature.com)
97.
Untangling the connection between dopamine and ADHD
(feeds.nature.com)
98.
ADHD is on the rise, but why?
(feeds.nature.com)
99.
This Is How GLP-1 Drugs Are Forcing Restaurant Chains to Change Their Menus
(feeds.feedburner.com)
100.
101.
102.
Hacker gets seven years for breaching Rotterdam and Antwerp ports
(bleepingcomputer.com)
103.
Funding for Risky Biotechs Is Returning
(feeds.content.dowjones.io)
104.
Ozempic is changing the foods Americans buy
(news.ycombinator.com)
105.
Ozempic reduced grocery spending by an average of 5.3% in the US
(news.ycombinator.com)
106.
107.
108.
109.
Ozempic Quitters Pay a Heavy Price, Research Shows
(gizmodo.com)
110.
Revolution Medicines Draws Takeover Interest
(feeds.content.dowjones.io)
111.
AbbVie Near Deal for Revolution Medicines
(feeds.content.dowjones.io)
112.
Something Grim Is Happening to People Who Go Off GLP-1s
(futurism.com)
113.
Tips from pharmacists to lower your out-of-pocket drug costs
(feeds.feedburner.com)
114.
Drugmakers raise US prices on 350 medicines despite pressure
(news.ycombinator.com)
115.
People Jabbing Themselves With Black Market “GLP-3” Drugs
(futurism.com)
116.
117.
Wegovy is coming in pill form. Here’s when, how much, and how well it works
(feeds.feedburner.com)
118.
Lawsuits Allege Ozempic Is Causing Blindness
(futurism.com)
119.
ProPublica’s New Tool Provides Drug Info the FDA Won’t
(gizmodo.com)
120.
Heart and Kidney Diseases and Type 2 Diabetes May Be One Ailment
(news.ycombinator.com)